Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1126, doi. 10.1038/gt.2008.24
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2008 AND VI 15 AND IP 15
Results: 8
1
2
Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1090, doi. 10.1038/gt.2008.49
- By:
- Publication type:
- Article
3
Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1079, doi. 10.1038/gt.2008.50
- By:
- Publication type:
- Article
4
A canine minidystrophin is functional and therapeutic in mdx mice.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1099, doi. 10.1038/gt.2008.70
- By:
- Publication type:
- Article
5
Cell-specific nuclear import of plasmid DNA in smooth muscle requires tissue-specific transcription factors and DNA sequences.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1107, doi. 10.1038/gt.2008.83
- By:
- Publication type:
- Article
6
Isolation of myogenic progenitor populations from Pax7-deficient skeletal muscle based on adhesion characteristics.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1116, doi. 10.1038/gt.2008.86
- By:
- Publication type:
- Article
7
AAV-dependent targeting of myostatin function: Follistatin strikes back at muscular dystrophy.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1075, doi. 10.1038/gt.2008.95
- By:
- Publication type:
- Article
8
Treatments for muscular dystrophy: Increased treatment options for Duchenne and related muscular dystropies.
- Published in:
- Gene Therapy, 2008, v. 15, n. 15, p. 1077, doi. 10.1038/gt.2008.97
- By:
- Publication type:
- Article